Page last updated: 2024-08-23

bisantrene and Cancer of Lung

bisantrene has been researched along with Cancer of Lung in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clark, G; Coltman, CA; Kuhn, J; Myers, JW; Pocelinko, R; Sandbach, JF; Von Hoff, DD	1
Aisner, J; Fuks, JZ; Garbino, C; Kasdorf, H; Van Echo, DA	1
Clark, GM; Coltman, CA; Myers, JW; Von Hoff, DD	1
Cowan, JD; Osborne, CK; Sandbach, J; Von Hoff, DD	1
Blough, RR; Cobleigh, MA; Johnson, CM; Kukla, LJ; Lad, TE; Lanzotti, VJ; McGuire, WP; Stiff, PJ; Zawila, P	1
Alberts, DS; Mackel, C; Pocelinko, R; Salmon, SE	1
Coltman, CA; Kuhn, JG; Myers, JW; Pocelinko, R; Rivkin, S; Van Echo, D; Von Hoff, DD	1
Comis, R; Green, MR; Propert, KJ; Vosika, G; Ware, JH	1
Deboer, G; Evans, WK; Feld, R; Ottema, B; Shepherd, FA	1
Ahmann, FR; Alberts, DS; Greenberg, BR; Mackel, C; Miller, TP	1

Trials

1 trial(s) available for bisantrene and Cancer of Lung

Article	Year
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay. Cancer research, 1982, Volume: 42, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Colony-Forming Units Assay; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms	1982

Article

Year

Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.

Cancer research, 1982, Volume: 42, Issue:3

Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antineoplastic Agents; Cell Survival; Clinical Trials as Topic; Colony-Forming Units Assay; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Male; Melanoma; Middle Aged; Multiple Myeloma; Neoplasms; Urinary Bladder Neoplasms

1982

Other Studies

9 other study(ies) available for bisantrene and Cancer of Lung

Article	Year
Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (CL216,942). Cancer research, 1981, Volume: 41, Issue:8 Topics: Adult; Aged; Anthracenes; Antineoplastic Agents; Bone Marrow; Carcinoma, Hepatocellular; Drug Evaluation; Female; Humans; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis	1981
Treatment of advanced non-small cell lung cancer with bisantrene. Cancer treatment reports, 1983, Volume: 67, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Leukocyte Count; Leukopenia; Lung Neoplasms; Male; Middle Aged	1983
Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer. Cancer treatment reports, 1984, Volume: 68, Issue:6 Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Carcinoma, Small Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged	1984
Bisantrene, an active drug in patients with advanced breast cancer. Cancer treatment reports, 1984, Volume: 68, Issue:2 Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Breast Neoplasms; Drug Evaluation; Female; Humans; Leukopenia; Lung Neoplasms; Nausea; Phlebitis	1984
Phase II trial of bisantrene for unresectable non-small cell bronchogenic carcinoma: an Illinois Cancer Council study. Cancer treatment reports, 1983, Volume: 67, Issue:9 Topics: Adult; Aged; Anthracenes; Carcinoma, Bronchogenic; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged	1983
Phase II evaluation of bisantrene in patients with renal cell carcinoma. Cancer treatment reports, 1982, Volume: 66, Issue:10 Topics: Adenocarcinoma; Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Bone Neoplasms; Drug Evaluation; Female; Humans; Leukocyte Count; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged	1982
Bisantrene in non-small cell lung cancer: a phase II trial of the Cancer and Leukemia Group B. Cancer treatment reports, 1986, Volume: 70, Issue:4 Topics: Anthracenes; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Time Factors	1986
Phase II evaluation of bisantrene in patients with advanced non-small cell lung carcinoma. Cancer treatment reports, 1985, Volume: 69, Issue:2 Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged	1985
Phase II trial of bisantrene in non-small cell lung cancer. Investigational new drugs, 1985, Volume: 3, Issue:4 Topics: Aged; Anthracenes; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged	1985